关注
Cecilie Bo Hansen
Cecilie Bo Hansen
Medical Doctor, University of Copenhagen
在 regionh.dk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors
L Pérez-Alós, JJA Armenteros, JR Madsen, CB Hansen, I Jarlhelt, ...
Nature communications 13 (1), 1614, 2022
1512022
Comparison of 16 serological SARS-CoV-2 immunoassays in 16 clinical laboratories
LH Harritshøj, M Gybel-Brask, S Afzal, PR Kamstrup, CS Jørgensen, ...
Journal of Clinical Microbiology 59 (5), 10.1128/jcm. 02596-20, 2021
1362021
SARS-CoV-2 antibody responses are correlated to disease severity in COVID-19 convalescent individuals
CB Hansen, I Jarlhelt, L Pérez-Alós, L Hummelshøj Landsy, M Loftager, ...
The Journal of Immunology 206 (1), 109-117, 2021
1212021
SARS-CoV-2 antibodies mediate complement and cellular driven inflammation
I Jarlhelt, SK Nielsen, CXH Jahn, CB Hansen, L Pérez-Alós, A Rosbjerg, ...
Frontiers in immunology 12, 767981, 2021
552021
The levels of the lectin pathway serine protease MASP-1 and its complex formation with C1 inhibitor are linked to the severity of hereditary angioedema
CB Hansen, D Csuka, L Munthe-Fog, L Varga, H Farkas, KM Hansen, ...
The Journal of Immunology 195 (8), 3596-3604, 2015
452015
Humoral response to two doses of BNT162b2 vaccination in people with HIV
LD Heftdal, AD Knudsen, SR Hamm, CB Hansen, DL Møller, ...
Journal of internal medicine 291 (4), 513-518, 2022
362022
SARS-CoV-2 neutralizing antibody responses towards full-length spike protein and the receptor-binding domain
R Bayarri-Olmos, M Idorn, A Rosbjerg, L Pérez-Alós, CB Hansen, ...
The Journal of Immunology 207 (3), 878-887, 2021
362021
Decline in antibody concentration 6 months after two doses of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients and healthy controls
SR Hamm, DL Møller, L Pérez-Alós, CB Hansen, MM Pries-Heje, ...
Frontiers in immunology 13, 832501, 2022
322022
The alpha/B. 1.1. 7 SARS-CoV-2 variant exhibits significantly higher affinity for ACE-2 and requires lower inoculation doses to cause disease in K18-hACE2 mice
R Bayarri-Olmos, LB Johnsen, M Idorn, LS Reinert, A Rosbjerg, S Vang, ...
Elife 10, e70002, 2021
302021
Complement related pattern recognition molecules as markers of short-term mortality in intensive care patients
CB Hansen, R Bayarri-Olmos, MK Kristensen, K Pilely, D Hellemann, ...
Journal of Infection 80 (4), 378-387, 2020
302020
SARS-CoV-2 natural antibody response persists for at least 12 months in a nationwide study from the Faroe Islands
MS Petersen, CB Hansen, MF Kristiansen, JP Fjallsbak, S Larsen, ...
Open Forum Infectious Diseases 8 (8), ofab378, 2021
242021
Functional effects of receptor-binding domain mutations of SARS-CoV-2 B. 1.351 and P. 1 variants
R Bayarri-Olmos, I Jarlhelt, LB Johnsen, CB Hansen, C Helgstrand, ...
Frontiers in immunology 12, 757197, 2021
222021
Antibody‐dependent neutralizing capacity of the SARS‐CoV‐2 vaccine BNT162b2 with and without previous COVID‐19 priming
CB Hansen, I Jarlhelt, RB Hasselbalch, SR Hamm, K Fogh, ...
Journal of Internal Medicine 290 (6), 1272, 2021
192021
Anti-SARS-CoV-2 seropositivity among medical students in Copenhagen
JR Madsen, JPS Nielsen, K Fogh, CB Hansen, PB Nielsen, T Lange, ...
Open forum infectious diseases 8 (8), ofab273, 2021
182021
Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
L Pérez-Alós, CB Hansen, JJ Almagro Armenteros, JR Madsen, ...
Nature Communications 14 (1), 5624, 2023
172023
Prediction of respiratory failure and mortality in COVID-19 patients using long pentraxin PTX3
CB Hansen, H Sandholdt, MEE Møller, L Pérez-Alós, L Pedersen, ...
Journal of Innate Immunity 14 (5), 493-501, 2022
172022
Recurrent injection‐site reactions after incorrect subcutaneous administration of a COVID‐19 vaccine.
M Gyldenløve, L Skov, CB Hansen, P Garred
Journal of the European Academy of Dermatology & Venereology 35 (9), 2021
172021
Self-reported long COVID and its association with the presence of SARS-CoV-2 antibodies in a Danish cohort up to 12 months after infection
K Fogh, TG Larsen, CB Hansen, RB Hasselbalch, ARR Eriksen, ...
Microbiology spectrum 10 (6), e02537-22, 2022
152022
Expression of complement C3, C5, C3aR and C5aR1 genes in resting and activated CD4+ T cells
CB Hansen, A Willer, R Bayarri-Olmos, C Kemper, P Garred
Immunobiology 224 (2), 307-315, 2019
142019
Factors influencing the immune response over 15 months after SARS‐CoV‐2 infection: A longitudinal population‐wide study in the Faroe Islands
MS Petersen, L Pérez‐Alós, JJA Armenteros, CB Hansen, JP Fjallsbak, ...
Journal of Internal Medicine 293 (1), 63-81, 2023
112023
系统目前无法执行此操作,请稍后再试。
文章 1–20